Conception et synthèse d'antagonistes des récepteurs sérotoninergiques 5-HT₃ = Design and synthesis of serotoninergic 5-HT₃ receptor antagonistsRampillon-Garcia, Valérie; Langlois, M.1994, 199 p.Thesis

Ultrastructure of the 5-hydroxytryptamine₃ receptorBOESS, F. G; BEROUKHIM, R; MARTIN, I. L et al.Journal of neurochemistry. 1995, Vol 64, Num 3, pp 1401-1405, issn 0022-3042Article

CYP2D6- and CYP3A-Dependent Enantioselective Plasma Concentrations of Ondansetron in Postanesthesia CareSTAMER, Ulrike M; LEE, Eun-Hae; RAUERS, Neele I et al.Anesthesia and analgesia. 2011, Vol 113, Num 1, pp 48-54, issn 0003-2999, 7 p.Article

A cytoplasmic region determines single-channel conductance in 5-HT₃ receptorsKELLEY, Stephen P; DUNLOP, James I; KIRKNESS, Ewen F et al.Nature (London). 2003, Vol 424, Num 6946, pp 321-324, issn 0028-0836, 4 p.Article

Distribution of [³H]GR65630 binding in human brain postmortemMARAZZITI, Donatella; BETTI, Laura; GIANNACCINI, Gino et al.Neurochemical research. 2001, Vol 26, Num 3, pp 187-190, issn 0364-3190Conference Paper

5-HT₃ receptors and the neural actions of alcohols : an increasingly exciting topicLOVINGER, D. M.Neurochemistry international. 1999, Vol 35, Num 2, pp 125-130, issn 0197-0186Article

Effect of pulverization on dehydration behavior of crystals of GK-128, a serotonin₃ receptor antagonistITO, S; KOBAYASHI, Y; NISHIMURA, M et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 10, pp 1117-1122, issn 0022-3549Article

Immunological characterization and transmembrane topology of 5-hydroxytryptamine₃ receptors by functional epitope taggingMUKERJI, J; HAGHIGHI, A; SEGUELA, P et al.Journal of neurochemistry. 1996, Vol 66, Num 3, pp 1027-1032, issn 0022-3042Article

Stability of ondansetron hydrochloride injection in various beveragesWEERANUJ YAMREUDEEWONG; DANTHI, S. N; HILL, R. A et al.American journal of health-system pharmacy. 1995, Vol 52, Num 18, pp 2011-2014, issn 1079-2082Article

Inadvertent epidural injection of ondansetronHUANG, Jeffrey J.Journal of clinical anesthesia. 2006, Vol 18, Num 3, pp 216-217, issn 0952-8180, 2 p.Article

Optimal timing of acustimulation for antiemetic prophylaxis as an adjunct to ondansetron in patients undergoing plastic surgeryWHITE, Paul F; HAMZA, Mohamed A; RECART, Alejandro et al.Anesthesia and analgesia. 2005, Vol 100, Num 2, pp 367-372, issn 0003-2999, 6 p.Article

Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factorsKOCH, K. M; CORRIGAN, B. W; MANZO, J et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 2, pp 223-230, issn 0269-2813, 8 p.Article

Transdermal delivery of ondansetron hydrochloride: Effects of vehicles and penetration enhancersHYE SUN GWAK; IK SANG OH; IN KOO CHUN et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 187-194, issn 0363-9045, 8 p.Article

Pharmacological survey of medicinal plants for activity at ligand-gated ion channels: Selective interaction with 5-HT3 receptorsLUEDTKE, Robert R; BELL-HORNER, Cathy L; VOLK, Michael et al.Pharmaceutical biology. 2004, Vol 42, Num 1, pp 73-82, issn 1388-0209, 10 p.Article

Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT₃ receptorDOUCET, E; MIQUEL, M. C; NOSJEAN, A et al.Neuroscience. 2000, Vol 95, Num 3, pp 881-892, issn 0306-4522Article

Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous systemMORALES, M; BATTENBERG, E; DE LECEA, L et al.Molecular brain research. 1996, Vol 36, Num 2, pp 251-260, issn 0169-328XArticle

Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance taskPITSIKAS, N; BORSINI, F.European journal of pharmacology. 1996, Vol 311, Num 2-3, pp 115-119, issn 0014-2999Article

Utilización de ondansetrón en urgencias de pediatría = Ondansetron use in paediatric emergenciesSANCHEZ ETXANIZ, J; PANIAGUA CALZON, N; GOMEZ CORTES, B et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 72, Num 5, pp 369-370, issn 1695-4033, 2 p.Article

Activation of cholecystokinin (CCK₁) and serotonin (5-HT₃) receptors increases the discharge of pancreatic vagal afferentsMUSSA, Bashair M; SARTOR, Daniela M; VERBEME, Anthony J. M et al.European journal of pharmacology. 2008, Vol 601, Num 1-3, pp 198-206, issn 0014-2999, 9 p.Article

Ondansetron oral disintegrating tablets : Acceptability and efficacy in children undergoing adenotonsillectomyCOHEN, Ira Todd; JOFFE, Denise; HUMMER, Kelly et al.Anesthesia and analgesia. 2005, Vol 101, Num 1, pp 59-63, issn 0003-2999, 5 p.Article

Postsynaptic target regulates functional responses induced by 5-HT₃ serotonin receptors on axonal varicosities of NG108-15 hybrid neuroblastoma cellsRONDE, P; NICHOLS, R. A.Neuroscience. 2001, Vol 102, Num 4, pp 979-987, issn 0306-4522Article

Antibodies against the extracellular domain of the 5-HT₃ receptor label both native and recombinant receptorsSPIER, A. D; WOTHERSPOON, G; NAYAK, S. V et al.Molecular brain research. 1999, Vol 67, Num 2, pp 221-230, issn 0169-328XArticle

Assignment of a human homolog of the mouse Htr3 receptor gene to chromosome 11q23.1-q23.2WEISS, B; MERTZ, A; SCHRÖCK, E et al.Genomics (San Diego, Calif.). 1995, Vol 29, Num 1, pp 304-305, issn 0888-7543Article

Evidence that the atypical 5-HT₃ receptor ligand, [³H]-BRL46470, labels additional 5-HT₃ binding sites compared to [³H]-granisetronSTEWARD, L. J; JIAN GE; BENTLEY, K. R et al.British journal of pharmacology. 1995, Vol 116, Num 2, pp 1781-1788, issn 0007-1188Article

Synthesis and structural, conformational, biochemical, and pharmacological study of new compounds derived from tropane-3-spiro-4'(5')-imidazoline as potential 5-HT₃ receptor antagonistsWHELAN, B. A; IRIEPA, I; GALVEZ, E et al.Journal of pharmaceutical sciences. 1995, Vol 84, Num 1, pp 101-106, issn 0022-3549Article